Nordic Precision Medicine Forum
27-28 April 2023 | Stockholm
Agenda
The agenda for 2023 is currently in production and will be released soon. To be informed when it is available, please contact us.
Speaking
From keynotes to panel discussions, industry satellites to posters, speaking at our Forum puts you in front of the right people. Speaking opportunities are limited so if you feel you have something you can bring to the table please contact us.
Sponsor
The foundation, and we believe the success of our events, lies in the preparation. Extensive research, engagement with industry leaders and targeted marketing campaigns ensure that we produce timely, relevant programmes, and bring the right people together.
Our Speakers
Speakers for Precision Oncology Forum comprises C-Level multidisciplinary group of experts drawn from healthcare, industry, patient groups, research, payers and Government. The programme is currently in production. We will be releasing the confirmed speakers soon and a full agenda in the summer 2022.
For speaking opportunities please contact Steve Coldicott.

Nils Olav Refsdal
Assistant director general in the Unit for skills, research and innovation in the Norwegian Ministry of Health and Care Services

Peter Asplund
Co-founder and Project Director MEGALIT. Director Department of Anestethic and Intensive Care, Region Örebro Län, Örebro, Sweden

Begonya Nafria Escalera
Patient Engagement in Research Coordinator at Sant Joan de Déu Chidren’s Hospital

Prof. Kristian Hveem
Kristian Hveem,Professor in Medicine and Clinical Epidemiology at the Faculty of Medicine and Health Sciences, at the NTNU



Johan Kolmert
Assistant professor in the Unit for Integrative Metabolomics, the Institute of Environmental Medicine, Karolinska Institute


Dr Katharina Wassilew
Consultant Histopathologist, Royal Brompton and Harefield Hospitals, Part of Guy’s and St. Thomas’ NHS Foundation Trust

Prof. Paul Franks
Professor at the Harvard School of Public Health in Boston and at Lund University in Sweden, Director of Translational Medicine at the Novo Nordisk Foundation

Dr Graham Belfield
Director of NGS & Transcriptomics within Translational Genomics at AstraZeneca’s R&D site in Gothenburg, Sweden.

Dr. Katriina Peltola
Chief Physician at Helsinki Comprehensive Cancer Center, Clinical Trial Unit













